Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Author Archives: PharmAust

Top 20 Shareholders January 2019

News & Announcements 2019, Top 20 ShareholdersBy PharmAust06/02/2019

Top_Holder_-_Detail_-_Single_Date january

Tablet Scaled Manufacture for Phase I Trials

News & Announcements 2019By PharmAust06/02/2019

190207_ScaledTablets

Phase I Trial Design

News & Announcements 2019By PharmAust06/02/2019

190207_PhaseIDesign

December 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2019, News & Announcements 2019By PharmAust31/01/2019

190131_4C

PharmAust and Elanco Data Sharing Agreement for Dog Trials

News & Announcements 2019By PharmAust28/01/2019

190129_Elanco_tox_package

Monepantel uptake responds to diet and tablet design

News & Announcements 2019By PharmAust21/01/2019

190121_Optimisation of Monepantel Uptake

Monepantel Metabolite Shows Anticancer Activity

News & Announcements 2019By PharmAust15/01/2019

190115_metabolite

Top 20 Shareholders 30th December 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust07/01/2019

December Top_Holder_-_Detail_-_Single_Date

Top 20 Shareholders 14 December 2018

News & Announcements 2018By PharmAust17/12/2018

Top_Holders_Report (14)Download

PharmAust Manufacturing Method Maintains Drug Potency

News & Announcements 2018By PharmAust02/12/2018

440ws7dgb0lrfl

←1
234567891011121314151617181920212223242526
…2728293031…
3233343536373839404142434445464748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun 2024

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun 2024

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2025 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top